Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Communication and dissemination plan: Details on the dissemination strategy and action plan including analysis of stakeholder groups, identification of key events and activities (opens in new window)

Communication and dissemination plan: Details on the dissemination strategyand action plan including analysis of stakeholder groups, identification of keyevents and activities

Project Quality Plan (PQP): rules for meetings management, documents naming and storage, deliverables preparation and quality review (opens in new window)

Project Quality Plan (PQP): rules for meetings management, documents namingand storage, deliverables preparation and quality review

Study initiation package – RISP (opens in new window)

Study initiation package-RISP (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Midterm recruitment report – PREVALUNG ETOILE (opens in new window)

Midterm recruitment report-PREVALUNG ETOILE: This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.

Project Management Plan (PMP): organisation, scope of work, Master Plan, Project Action List, risk register (opens in new window)

Project Management Plan (PMP): organisation, scope of work, Master Plan,Project Action List, risk register

First meeting of the PAB minutes (opens in new window)
Report on the status of posting results in a repository – FLEMENGHO (opens in new window)

Report on the status of posting results in a repository-FLEMENGHO. Irrespective of the successful completion of the clinical study, summary results must be posted in the applicable registry/ies (where the study was registered) even if the timing of posting of results falls outside of the grant period. The report is to be scheduled for the time results posting is expected or for the last months of the project, whichever comes earlier.

Midterm recruitment report – SUMMIT (opens in new window)

Midterm recruitment report-SUMMIT: This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.

Management Board charts signed by members (opens in new window)
Midterm recruitment report – PREVALUNG (opens in new window)

Midterm recruitment report- PREVALUNG: This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.

Midterm recruitment report – ROBINSCA (opens in new window)

Midterm recruitment report-ROBINSCA: This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.

Study initiation package – SUMMIT (opens in new window)

Study initiation package-SUMMIT (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Study initiation package – FLEMENGHO (opens in new window)

Study initiation package-FLEMENGHO (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Study initiation package – PREVALUNG ETOILE (opens in new window)

Study initiation package-PREVALUNG ETOILE (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Study initiation package – ROBINSCA (opens in new window)

•Study initiation package-ROBINSCA (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Study initiation package – NCL TLHC (opens in new window)

Study initiation package-NCL TLHC (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Study initiation package – PREVALUNG (opens in new window)

Study initiation package- PREVALUNG (before enrolment of the first study participant) including:oRegistration number of the clinical study in a registry meeting WHO Registry criteriaoFinal version of study protocol as approved by the regulator(s) / ethics committee(s)oRegulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)

Midterm recruitment report – FLEMENGHO (opens in new window)

Midterm recruitment report-FLEMENGHO: This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.

Visual identity, website and social media: Project branding, introductory project materials, video, infographics, logo are available, website is published and social media accounts operative (opens in new window)

Visual identity, website and social media: Project branding, introductory projectmaterials, video, infographics, logo are available, website is published andsocial media accounts operative

Publications

1510 Multiomic functional biomarkers for cancer prediction and early detection (opens in new window)

Author(s): Marine Fidelle, Deborah Suissa, Roxanne Birebent, et al
Published in: Journal for immunotherapy of cancer, Issue 11, 2023, ISSN 2051-1426
Publisher: BMJ Publishing Group Ltd & Society for Immunotherapy of Cancer
DOI: 10.1136/jitc-2023-SITC2023.1510

Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance (opens in new window)

Author(s): Marine Fidelle, Ai-Ling Tian, Laurence Zitvogel, Guido Kroemer
Published in: Oncoimmunology, Issue 12, 2023
Publisher: Taylor & Francis Group
DOI: 10.1080/2162402X.2023.2224672

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available